Please login to the form below

Not currently logged in
Email:
Password:

Kantar Health promotes Graeme Jacombs to managing director, APMEA

He will be responsible for regional strategy, local business planning and client support across the region

Kanter Health Graeme JacombsKantar Health has promoted Graeme Jacombs to managing director of the Asia Pacific, Middle East and Africa (APMEA) region.

He has been with Kantar Health and its legacy companies serving in a variety of roles across this region since 1993, most recently as the market research and consultancy firm's deputy managing director, APMEA.

In his new role, Jacombs will be responsible for Kantar Health's regional strategy, local business planning and client support in Asia, Australia/New Zealand, India, the Middle East and Africa.

“I am so pleased to appoint Graeme as managing director, APMEA. He has been instrumental in building Kantar Health in this dynamic region,” said Lynnette Cooke, Kantar Health global CEO.

“Graeme's 20 years of experience in Asia Pacific and across a wealth of therapeutic areas provide him with the unique ability to act as trusted adviser to clients. He has proven experience when it comes to providing clients with global reach and strong local insight.”

11th September 2012

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics